Answers are grounded in this paper and cite their sources.
Background: Lipocalin-2 is involved in various pathological conditions, such as inflammation, acute organdamage, glucose tolerance abnormalities and cancer. Lipocalin-2 is also related to reactive astrocytes in animalmodels of cerebral ischemia and traumatic brain injury (TBI). This study used a rat model of cortical contusioninjury (CCI) to observe serial changes in lipocalin-2 in brain tissue and blood over time and investigated its usefulness as a biomarker after TBI.Materials and Methods: The CCI model used in this study was male Crl:CD (Sprague–Dawley) rats. The experimental groups were divided into mild and severe groups on the basis of compression. This study examined whether the expression of lipocalin-2 significantly increased in brain tissue and blood after cortical contusion in a ratTBI model. Polymerase chain reaction (PCR) was used to quantify the expression of lipocalin-2 in brain tissue,and Western blotting and enzyme-linked immunosorbent assay (ELISA) were used to assess lipocalin-2 expression in brain tissue and blood after injury in rats.Results: PCR revealed lipocalin-2 expression in all the groups. The expression of lipidalin-2 on the side ipsilateral to the TBI site was significantly elevated at 1, 3 and 24 hours after trauma in both the mild and severe groups.Lipocalin-2 in the blood increased significantly at 3, 6 and 24 hours after trauma in the mild group and immediately after and at 1, 3, 6 and 24 hours after trauma in the severe group.Conclusion: These findings suggest that lipocalin-2 may be closely involved in the physiological condition aftersecondary damage due to TBI and may be useful as a biomarker to predict clinical outcomes after injury.
No takes yet. Share an insight, caveat, or question.
Otaki et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: